Paired Tumor-Germline Testing as a Driver in Better Cancer Care

Abstract

provide an analysis of paired tumor-germline next-generation sequencing (NGS) in a large population of patients with cancer. One implication of the data is that paired testing provides important information about a patient's cancer and its treatment and can address hereditary issues of importance to the patient's family. This commentary considers the advantages of paired tumorgermline testing in cancer care.

Topics & Concepts